Incorrect username and/or password, please try again or click to reset.

Class 4 Medicines Defect Information: GlaxoSmithKline UK Ltd, Zovirax I.V. 500 mg, EL (22)A/22

2022-05-09 10:00:45 (2 month(s) ago)

Summary

GlaxoSmithKline UK Ltd have informed the MHRA that an incorrect version of the Summary of Product Characteristics section 4.2 and the Patient Information Leaflet is inside the sealed pack, and contains unapproved text.

Read full MHRA article

Respond to this alert